ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 397,25
0,09%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Psychemedics Corporation (PMD)

  7. Psychemedics Corporation (PMD) Actualités

PMD Psychemedics Corporation

2,25
-0,1814 (-7,46%)
07 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Psychemedics Corporation PMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,1814 -7,46% 2,25 23:30:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,31 2,25 2,43 2,25 2,4314
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/6/202422:37EDGAR2Form 8-K - Current report
14/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:56EDGAR2Form 8-K - Current report
14/5/202422:55GLOBEPsychemedics Corporation Reports First Quarter 2024..
28/3/202413:20GLOBEPsychemedics Corporation Reports 2023 Financial Results
21/3/202414:00GLOBEPsychemedics Recognized as a Top 10 Employee Health Testing..
13/2/202415:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202422:10EDGAR2Form 8-K - Current report
24/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202417:27GLOBEPsychemedics Corporation Announces Relocation of..
19/12/202322:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202318:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202317:31EDGAR2Form 8-K - Current report
27/11/202315:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
13/11/202323:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:00GLOBEPsychemedics Corporation Reports Third Quarter 2023..
09/11/202323:00EDGAR2Form 8-K - Current report
08/11/202323:00EDGAR2Form 8-K - Current report
27/10/202317:00GLOBEUnveiling the Future of Drug Testing: Psychemedics..
26/9/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202319:00EDGAR2Form 8-K - Current report
21/9/202323:00GLOBEPsychemedics Corporation Appoints Shannon Shoemaker as Chief..
31/8/202323:20EDGAR2Form 8-K - Current report
22/8/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202323:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/8/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202323:01EDGAR2Form 8-K - Current report
18/8/202320:00GLOBEPsychemedics Corporation Reports Inducement Grants Under..
17/8/202323:30EDGAR2Form 144 - Report of proposed sale of securities
14/8/202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202323:10GLOBEPsychemedics Corporation Reports Second Quarter 2023..
11/8/202323:10EDGAR2Form 8-K - Current report
21/7/202323:00EDGAR2Form 8-K - Current report
21/7/202322:00EDGAR2Form DEF 14A - Other definitive proxy statements
14/7/202315:15EDGAR2Form 8-K - Current report
12/7/202323:15GLOBEPsychemedics Corporation Announces CEO Succession Plan

Dernières Valeurs Consultées

NASDAQ
PMD
Psychemedics
NYSE
SON
Sonoco Products
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés